Table 1.
Description | COVID-19 1 | SARS 2 | MERS 3 | EVD 4 |
---|---|---|---|---|
Incubation period | 2–14 days | 2–10 days | 2–14 days | 2–21 days |
Contagious during incubation | Yes | Yes | Yes | No |
Vaccine release year | N/A | N/A | N/A | Dec. 2019 |
Infected body part | Blood vessels | Respiratory system | Respiratory system | All muscles |
Latest outbreak | Dec. 2019 | Nov. 2002–July 2003 | April 2012 | Dec. 2013–June 2016 |
July 2015 | ||||
Winter/summer impact | Likely | Likely | Not likely | Not likely |
Main transmission | Respiratory droplet secretions | Respiratory droplet secretions | Respiratory droplet secretions | Body fluids |
Shape and size in nm | Spherical 80–120 nm | Spherical 80–90 nm | Spherical 90–125 nm | Filament |
14,000 × 80 nm | ||||
Temperature impact | Likely | Likely | Likely | Likely |
Mortality rate | 2.65% | 14–15% | 34% | Up to 90% |
Pronounced R-naught | 2–2.5 | 3.1–4.2 | <1 | 1.5–1.9 |
1. COVID-19: Coronavirus Disease 2019; 2. SARS: Severe Acute Respiratory Syndrome; 3. MERS: Middle East respiratory syndrome; 4. EVD: Ebola Virus Disease.